| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $8,687,978 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01CA269897 | Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors | 002 | 4 | NIH | 3/3/2025 | $440,203 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AI191767 | Atlas of efflux and permeation determinants to advance antibacterial therapeutic discovery | 000 | 1 | NIH | 7/21/2025 | $1,120,070 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R21AI190246 | Interrogating stress and viral shedding in a migratory bat model | 000 | 1 | NIH | 7/21/2025 | $376,932 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01DC011579 | Taste and Somatosensory Processing | 001 | 14 | NIH | 5/20/2025 | $38,072 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01DC011579 | Taste and Somatosensory Processing | 000 | 14 | NIH | 2/18/2025 | $342,645 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R03AI175981 | Characterizing mechanisms of immune protection by the bacterial type II-A CRISPR systems | 000 | 2 | NIH | 1/3/2025 | $70,990 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM153297 | Multiscale Modeling of Enzymatic Reactions and Bioimaging Probes | 001 | 2 | NIH | 7/21/2025 | $352,487 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01DC020843 | Temperature and thermogustatory preferences | 000 | 3 | NIH | 6/25/2025 | $476,415 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | K25CA270079 | Computational approaches to the mechanistic elucidation of the serrated pathway of human colon carcinogenesis | 000 | 3 | NIH | 6/30/2025 | $198,721 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM151086 | Epigenetic and transcriptional mechanisms driving human pigmentation diversity | 000 | 3 | NIH | 8/7/2025 | $373,297 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R00ES033257 | Linking genomic, physiological, and behavioral responses using a Drosophila model of heavy metal stress | 000 | 5 | NIH | 8/11/2025 | $248,996 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM147397 | A multi-level mass spectrometry pipeline for the analysis of whole proteoforms and their complexes | 000 | 4 | NIH | 6/26/2025 | $380,398 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AT011618 | Proteomic Stable Isotope Probing as a Novel Approach for Linking Prebiotics with Active Gut Microbiota | 000 | 5 | NIH | 5/1/2025 | $351,194 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AI132836 | Permeability barriers of Gram-negative pathogens and approaches to bypass them | 000 | 8 | NIH | 3/31/2025 | $455,323 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM150970 | Enabled by drug delivery: Studying the role of brain-resident and infiltrating myeloid cell phenotype in brain damage associated with inflammatory disease | 000 | 3 | NIH | 8/13/2025 | $373,297 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | P20GM135009 | Oklahoma Center of Medical Imaging for Translational Cancer Research | 001 | 4 | NIH | 8/20/2025 | $226,218 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | P20GM135009 | Oklahoma Center of Medical Imaging for Translational Cancer Research | 000 | 4 | NIH | 1/7/2025 | $2,035,962 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AI187294 | Intermembrane transport of lipids and metabolites by mycobacterial MmpL protein complexes | 000 | 1 | NIH | 11/27/2024 | $811,396 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | NH28CE003511 | McClain County Drug Free Communities | 00 | 4 | CDC | 8/7/2025 | $125,000 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R21EY036599 | Chromosome Packing Inhibitors for the Treatment of Eye Infections | 000 | 2 | NIH | 8/25/2025 | $226,825 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM150758 | A novel framework for nanomedicine development | 000 | 3 | NIH | 7/18/2025 | $373,297 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM138800 | A Chemoenzymatic Approach to Accessing Novel Isoprenoid Scaffolds | 001 | 4 | NIH | 8/8/2025 | $31,029 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM138800 | A Chemoenzymatic Approach to Accessing Novel Isoprenoid Scaffolds | 000 | 4 | NIH | 12/12/2024 | $279,261 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM152704 | Development of protein-based nanostructures activated by ultrasound | 001 | 2 | NIH | 8/18/2025 | $35,099 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM152704 | Development of protein-based nanostructures activated by ultrasound | 000 | 2 | NIH | 1/27/2025 | $315,903 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | P30GM145423 | Oklahoma COBRE in Structural Biology | 000 | 4 | NIH | 5/26/2025 | $1,141,533 |
| | 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01CA269897 | Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors | 003 | 4 | NIH | 5/22/2025 | $48,911 |
| | 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01NS123051 | Single stage surgical intervention for treatment of severe traumatic brain injury | 005 | 3 | NIH | 5/7/2025 | -$30,888 |
| | 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01NS123051 | Single stage surgical intervention for treatment of severe traumatic brain injury | 004 | 3 | NIH | 5/7/2025 | -$50,829 |
| | 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01NS123051 | Single stage surgical intervention for treatment of severe traumatic brain injury | 002 | 3 | NIH | 4/25/2025 | $0 |
| | 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01NS123051 | Single stage surgical intervention for treatment of severe traumatic brain injury | 000 | 3 | NIH | 4/3/2025 | -$455,350 |
| | 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | H79SP084324 | South Southwest Prevention Technology Transfer Center (SSW PTTC) | 000 | 1 | SAMHSA | 3/13/2025 | $0 |
| | 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01CA269897 | Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors | 001 | 3 | NIH | 2/13/2025 | $0 |
| | 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R35GM153297 | Multiscale Modeling of Enzymatic Reactions and Bioimaging Probes | 000 | 1 | NIH | 11/7/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R25CA274172 | Native American Youths Enjoy Science - YES Oklahoma | 000 | 2 | NIH | 3/14/2025 | -$255,645 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R25HG010132 | Programs for the Training and Advancement of the Next GENeration of Native Researchers in Genetics, Ethics and Society | 002 | 5 | NIH | 4/29/2025 | -$14 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R25HG010132 | Programs for the Training and Advancement of the Next GENeration of Native Researchers in Genetics, Ethics and Society | 001 | 5 | NIH | 10/23/2024 | $0 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R21AR079705 | Peptide Discovery for Chondrogenesis | 000 | 2 | NIH | 6/25/2025 | $0 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AI177469 | Novel single-cell mass spectrometry methods to assess the role of intracellular drug concentration and metabolism in antimicrobial treatment failure | 000 | 1 | NIH | 12/11/2024 | -$1 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | F31CA261044 | Tumor-Specific Nanocontrast Agents for Improved Detection of Pancreatic Cancer | 001 | 2 | NIH | 12/20/2024 | -$1,200 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | F31CA261044 | Tumor-Specific Nanocontrast Agents for Improved Detection of Pancreatic Cancer | 000 | 2 | NIH | 11/25/2024 | -$2,413 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01HD109157 | Shift from Unilateral to Bilateral Sensory-Motor Connectivity in Chronic Hemiparetic Stroke | 001 | 2 | NIH | 2/26/2025 | -$1 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AI170605 | Deciphering the mechanism of action of carnitine, a novel treatment for chronic Chagas disease | 000 | 2 | NIH | 1/21/2025 | -$35,438 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | H79SP081152 | The STOP ACT Project (SAP) at the University of Oklahoma Southwest Prevention Center targets the local community conditions regarding alcohol use by youth and young adults ages 12-20. | 001 | 4 | SAMHSA | 1/13/2025 | -$50,000 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01GM138592 | Defining the mechanistic determinants of catalytic bias in cofactor-based enzymatic oxidation-reduction reactions | 000 | 5 | NIH | 8/6/2025 | $0 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | H79SP080985 | Implement and evaluate the Region 6 Prevention and Technology Transfer Center (PTTC) project for Health and Human Service Region 6, by providing high-impact training and technical assistance services. | 000 | 5 | SAMHSA | 4/9/2025 | -$83,449 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | H79SP081501 | The purpose of the SWPC SPF-PFS is to prevent the onset and reduce the progression of substance abuse and related problems while strengthening prevention capacity and infrastructure in the community. | 001 | 5 | SAMHSA | 2/14/2025 | -$300,000 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01AI141625 | Quantitative Analysis of Serum Autoantibody Repertories in Systemic Lupus Erythematosus | 000 | 5 | NIH | 4/16/2025 | -$24,767 |
| | 2025 | 2023 | UNIVERSITY OF OKLAHOMA | 660 PARRINGTON OVAL RM 301 | NORMAN | OK | 73019-3003 | CLEVELAND | USA | R01HL159475 | Improving outcomes in endovascular treatment of intracranial aneurysms: Combining additive manufacturing, in-silico modeling, and shape memory polymers | 001 | 2 | NIH | 3/19/2025 | -$660,306 |
|
